JOINT CORP/THE (JYNT)
US47973J1025 - Common Stock
Taking everything into account, JYNT scores 3 out of 10 in our fundamental rating. JYNT was compared to 117 industry peers in the Health Care Providers & Services industry. JYNT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. JYNT is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year JYNT has reported negative net income.
JYNT had a positive operating cash flow in the past year.
Of the past 5 years JYNT 4 years were profitable.
Each year in the past 5 years JYNT had a positive operating cash flow.
1.2 Ratios
JYNT's Return On Assets of -11.19% is on the low side compared to the rest of the industry. JYNT is outperformed by 66.38% of its industry peers.
With a Return On Equity value of -39.41%, JYNT is not doing good in the industry: 61.21% of the companies in the same industry are doing better.
JYNT has a Return On Invested Capital (0.83%) which is comparable to the rest of the industry.
JYNT had an Average Return On Invested Capital over the past 3 years of 3.17%. This is significantly below the industry average of 8.60%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.19% | ||
| ROE | -39.41% | ||
| ROIC | 0.83% |
ROA(3y)-0.61%
ROA(5y)5.15%
ROE(3y)-4.16%
ROE(5y)21.54%
ROIC(3y)3.17%
ROIC(5y)5.54%
1.3 Margins
JYNT has a Operating Margin (0.48%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of JYNT has declined.
JYNT has a better Gross Margin (91.04%) than 99.14% of its industry peers.
In the last couple of years the Gross Margin of JYNT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.48% | ||
| PM (TTM) | N/A | ||
| GM | 91.04% |
OM growth 3Y-62.75%
OM growth 5Y-26.26%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.79%
GM growth 5Y0.62%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so JYNT is destroying value.
Compared to 1 year ago, JYNT has more shares outstanding
JYNT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for JYNT is higher compared to a year ago.
2.2 Solvency
JYNT has an Altman-Z score of 2.88. This is not the best score and indicates that JYNT is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of JYNT (2.88) is better than 73.28% of its industry peers.
JYNT has a debt to FCF ratio of 0.21. This is a very positive value and a sign of high solvency as it would only need 0.21 years to pay back of all of its debts.
JYNT has a better Debt to FCF ratio (0.21) than 93.97% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that JYNT is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.08, JYNT is doing good in the industry, outperforming 77.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.21 | ||
| Altman-Z | 2.88 |
ROIC/WACC0.09
WACC9.28%
2.3 Liquidity
JYNT has a Current Ratio of 1.32. This is a normal value and indicates that JYNT is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.32, JYNT perfoms like the industry average, outperforming 48.28% of the companies in the same industry.
JYNT has a Quick Ratio of 1.32. This is a normal value and indicates that JYNT is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.32, JYNT perfoms like the industry average, outperforming 51.72% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.32 | ||
| Quick Ratio | 1.32 |
3. Growth
3.1 Past
JYNT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -925.00%.
Looking at the last year, JYNT shows a quite strong growth in Revenue. The Revenue has grown by 16.84% in the last year.
JYNT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.25% yearly.
EPS 1Y (TTM)-925%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-1975%
Revenue 1Y (TTM)16.84%
Revenue growth 3Y26.1%
Revenue growth 5Y26.25%
Revenue growth Q2Q12.76%
3.2 Future
JYNT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 61.33% yearly.
JYNT is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -8.16% yearly.
EPS Next Y106.8%
EPS Next 2Y61.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-4.57%
Revenue Next 2Y-8.16%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
JYNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 272.50, JYNT can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of JYNT is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of JYNT to the average of the S&P500 Index (21.49), we can say JYNT is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 272.5 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as JYNT.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of JYNT indicates a somewhat cheap valuation: JYNT is cheaper than 73.28% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.68 | ||
| EV/EBITDA | 17.77 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates JYNT does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as JYNT's earnings are expected to grow with 61.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y61.33%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for JYNT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
JOINT CORP/THE
NASDAQ:JYNT (4/26/2024, 7:00:02 PM)
After market: 12.23 0 (0%)12.23
+0.15 (+1.24%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap180.76M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 272.5 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.19% | ||
| ROE | -39.41% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 0.48% | ||
| PM (TTM) | N/A | ||
| GM | 91.04% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.32 | ||
| Quick Ratio | 1.32 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-925%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y106.8%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)16.84%
Revenue growth 3Y26.1%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y